Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Elanco Animal Health (NYSE:ELAN) through any online brokerage.
Other companies in Elanco Animal Health’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Elanco Animal Health has a consensus price target of $26.54.
The stock price for Elanco Animal Health (NYSE: ELAN) is $22.92 last updated October 9, 2026 at 4:00 PM EDT.
There are no upcoming dividends for Elanco Animal Health.
Elanco Animal Health does not have any upcoming earnings scheduled.
There is no upcoming split for Elanco Animal Health.
Elanco Animal Health is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.